Wikipedia:Articles for deletion/David R. Elmaleh


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was delete. Modussiccandi (talk) 07:22, 18 May 2022 (UTC)

David R. Elmaleh

 * – ( View AfD View log | edits since nomination)

dubious notability, virtually no hits on Google Scholar, created by an SPA with an interest in promoting this individual  F ASTILY   23:30, 24 April 2022 (UTC)
 * Note: This discussion has been included in the list of Academics and educators-related deletion discussions. Shellwood (talk) 06:12, 25 April 2022 (UTC)


 * keep - (I have connection with Elmaleh) David R. Elmaleh is an associate Professor at Harvard Medical School at Harvard University He has developed a number of drugs that are in use in man or in late stage of clinical trials. He is a co-author on over 130 publications (You can see his publications at ResearchGate) and an inventor on 140 of issued and pending patents (see list at Justia or at Google).
 * Please see this article about his work: Building Successful Businesses from Science-based Discovery - A Leadership Dialogue with DAVID ELMALEH, Mcgill.ca / Desautels Faculty of Management.


 * This article comply with the specific notability guideline for academics (WP:PROF):
 * Criterion 1 is to show that the academic has been an author of highly cited academic work - citations need to occur in peer-reviewed scholarly publications such as journals or academic books.
 * The person's research has had a significant impact in their scholarly discipline, broadly construed, as demonstrated by independent reliable sources.
 * thanks - Ovedc (talk) 10:34, 26 April 2022 (UTC)
 * where is the full disclosure ? User:ovedc was paid by David R. Elmaleh, you can see in the Hebrew wiki — Preceding unsigned comment added by 2a02:14f:1f7:cd15::327d:73cf (talk • contribs) 13:36, 26 April 2022 (UTC)
 * Well of course you !voted keep, you get paid to do so. -  F ASTILY   05:16, 28 April 2022 (UTC)

Please add new comments below this notice. Thanks, ✗  plicit  23:51, 1 May 2022 (UTC)
 * Delete Patents are not an indicator of notability whatsoever. The "article about his work" is a recap of a McGill University symposium that Elmaleh participated in located on McGill's website and written by their communications department. Wikipedia is not a resume or CV service. Best, GPL93 (talk) 20:15, 29 April 2022 (UTC)
 *  Relisted to generate a more thorough discussion and clearer consensus.
 * keep - I vote to keep as David Elmaleh meets the standards for academics, as his work is highly cited and influential. VeritasOM (talk) 01:16, 2 May 2022 (UTC) — VeritasOM (talk&#32;• contribs) has made few or no other edits outside this topic.


 * Delete most of his hits are press-releases or his name on patents. Almost vanity spam. Oaktree b (talk) 15:49, 2 May 2022 (UTC)
 * Interesting, Veritas is a novice editor, with a very few contributions, all of them afd, almost always vote for keep, scarce knowledge (in his field, the number of citations are meager, tiny), maybe he is a SP? — Preceding unsigned comment added by 2A02:14F:80:94D3:0:0:0:1 (talk) 16:28, 2 May 2022 (UTC)
 * says the "person" hiding behind in IP address. Regardless, I don't see notability. Oaktree b (talk) 19:47, 4 May 2022 (UTC)

Please add new comments below this notice. Thanks, Star   Mississippi  01:47, 9 May 2022 (UTC)
 *  Relisted to generate a more thorough discussion and clearer consensus.


 * Delete: Doesn't meet WP:NOTABILITY in my eyes Amadeus22  🙋 🔔 01:49, 9 May 2022 (UTC)
 * keep - (I have connection with Elmaleh) Prof. Elmaleh is a scientist, inventor and entrepreneur and an associate Professor at Harvard Medical School at Harvard University. He has many patents (justia, google) that some of them used at over a million PET imaging procedures (as Study Director). You can see article about him at Globes: From Musrara to Harvard: The serial entrepreneur who wants to beat Alzheimer's (In Hebrew). Ovedc (talk) 10:33, 11 May 2022 (UTC)
 * You are only allowed to !vote once. And in your case, as a declared paid contributor, I would suggest !voting not at all. —David Eppstein (talk) 18:37, 17 May 2022 (UTC)
 * Keep - He has invented drugs which is notable. Davidgoodheart (talk) 18:14, 14 May 2022 (UTC)
 * Delete. The subject has a moderate number of citations in a higher citation field, mostly as middle author on fairly highly coauthored papers.  It looks WP:RUNOFTHEMILL for an (apparently terminal) associate professor, and I'm not seeing it as adding up to WP:NPROF.  The Globes.co.il found by a COIed editor above is a start towards GNG and WP:BASIC, but I'm not seeing it as passing it by itself.  The article is not in great shape, and with marginal-at-best notability, WP:TNT may apply. Russ Woodroofe (talk) 09:40, 16 May 2022 (UTC)
 * Keep, what he has done is very credentialed and his article is well sourced. — Preceding unsigned comment added by 207.102.255.37 (talk) 18:22, 17 May 2022 (UTC)  — 207.102.255.37 (talk) has made few or no other edits outside this topic.


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.